NCT01032499

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir

Multicenter Clinical Study,Phase III, Prospective, Randomized, Open and Comparative to Measure Tolerability and Efficacy of Taro Elixir on the Evolution Treatment of Acne Vulgaris II and III Degree or of Furunculosis Compared With Oxytetracycline

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Laboratorios Goulart S.A. · Industry
• Sex: All
• Age: 14 Years
• Healthy volunteers: Not accepted

Summary

To measure the efficacy of Taro Elixir compare with Oxytetracycline in the treatment of boils or acne.

Conditions

• Acne Vulgaris II or III Degree
• Boils

Interventions

Type	Name	Description
DRUG	oxytetracycline, taro elixir	comparison of treatment efficacy between oxytetracycline and taro elixir
DRUG	Taro Elixir	Taken orally one tablespoon (15 mL) of Taro Elixir 3 times daily for breakfast, lunch and dinner.

Timeline

• Start date: 2010-05-01
• Primary completion: 2010-07-01
• Completion: 2010-10-01
• First posted: 2009-12-15
• Last updated: 2010-03-19

Locations

4 sites across 1 country: Brazil